Mannucci E, Mangia PP, Pradelli L. Clinical and Economic Rationale for the Early use of SGLT2 Inhibitors in Patients with Type 2 Diabetes. FE [Internet]. 2020 Dec. 23 [cited 2025 Jul. 23];21(1S). Available from: https://provafe.seedstm.com/index.php/FE/article/view/1490